MCE - Delayed Quote EUR
Coca-Cola Europacific Partners PLC (CCEP.MC)
77.80
-0.50
(-0.64%)
As of 1:00:00 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 2 | 15 | 15 |
| Avg. Estimate | 4.68B | 5.5B | 21.38B | 22.16B |
| Low Estimate | 4.56B | 5.49B | 21.09B | 21.79B |
| High Estimate | 4.78B | 5.51B | 21.65B | 22.53B |
| Year Ago Sales | 4.46B | 5.36B | 20.44B | 21.38B |
| Sales Growth (year/est) | 4.81% | 2.57% | 4.59% | 3.69% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CCEP.MC | -- | -- | -- | -- |
| S&P 500 | 9.62% | 4.20% | 8.36% | 13.90% |
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 4/11/2025 |
| Maintains | Barclays: Overweight to Overweight | 3/27/2025 |
| Maintains | Barclays: Overweight to Overweight | 3/6/2025 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 2/18/2025 |
| Maintains | Barclays: Overweight to Overweight | 1/17/2025 |
| Maintains | UBS: Buy to Buy | 12/12/2024 |